Fundz

Philip Morris International Acquires Inhaled Drug Specialist Otitopic; Growing Pipeline Of “Beyond Nicotine” Inhaled Therapeutic Products

PUBLIC · PMAug 09, 2021

Acquiring Company

Philip Morris International

Acquired Company

OtiTopic

StamfordManufacturingBiotechnologyAgriculture and FarmingHealth CareGovernmentCannabis

Description

Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. If approved, the treatment can address the significant unmet medical need of the over 83 million people, in the U.S. alone, at intermediate to high risk for myocardial infarction.

Quick answer

Philip Morris International is acquiring OtiTopic, announced August 9, 2021. Philip Morris International is based in Stamford, Connecticut, United States.

How much did Philip Morris International pay for OtiTopic?
The deal value was not disclosed.
What does Philip Morris International do?
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine..
Where are Philip Morris International and OtiTopic based?
Philip Morris International is based in Stamford, Connecticut, United States.
Who are the decision-makers at Philip Morris International?
Fundz holds 1 contact at Philip Morris International. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Agriculture and Farming and Government

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Philip Morris International, and when

When Philip Morris International changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Philip Morris International raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Philip Morris International, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Philip Morris International. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Philip Morris International

Location

677 Washington Blvd, Ste. 1100

Stamford, Connecticut, United States

About

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Since 2008, PMI has invested more than USD 14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Philip Morris International makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Travis
Likely contact at this company
••••••••@••••••••

See Travis's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Philip Morris International's next move

Learn about Strategic plan

Frequently asked

Who acquired OtiTopic?

OtiTopic was acquired by Philip Morris International, based in Stamford. The deal was reported on August 9, 2021. Philip Morris International is publicly traded (PM) and operates in Manufacturing.

When did Philip Morris International acquire OtiTopic?

Philip Morris International's acquisition of OtiTopic was reported on August 9, 2021. Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does OtiTopic do?

OtiTopic is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.